Industry Archives - Page 8 of 22 - EverGlade

Industry

DARPA MARRS to Advance Solid-State Fusion at Room Temperature

DARPA Launches MARRS to Advance Solid-State Fusion at Room Temperature

Leave a Comment / DARPA, Emerging Technologies / By

Broad Agency Announcement: MARRS HR001126S0007 The Defense Advanced Research Projects Agency (DARPA) has released a new Broad Agency Announcement (BAA) under its Defense Sciences Office (DSO) titled Mechanisms for Amplification of Fusion Reaction Rates in Solids (MARRS). Through MARRS, DARPA seeks to explore whether nuclear fusion reactions operating at or near room temperature in solid […]

DARPA Launches MARRS to Advance Solid-State Fusion at Room Temperature Read More »

DARPA’s Generative Optogenetics (GO) Program

DARPA’s Generative Optogenetics (GO) Program

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-PS-26-10 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released a new program solicitation for Generative Optogenetics (GO), a bold, high-risk, high-reward research effort aimed at redefining how genetic information is delivered to living cells. Announced on December 19, 2025, this solicitation reflects DARPA’s continued investment in foundational biological

DARPA’s Generative Optogenetics (GO) Program Read More »

ARPA-H BioStabilization Systems (BoSS) Program

ARPA-H Launches the BioStabilization Systems (BoSS) Program to Transform Cell Therapy Distribution

Leave a Comment / ARPA-H, Life Sciences / By

BOSS_ISO_Final_01Dec2025 The Advanced Research Projects Agency for Health (ARPA-H) has announced a landmark Innovative Solutions Opening (ISO) for the BioStabilization Systems (BoSS) program, an ambitious effort to revolutionize how live cell-based therapies are stabilized, manufactured, and distributed. As outlined in the solicitation, BoSS aims to eliminate the field’s dependence on ultra-cold storage and transport, which

ARPA-H Launches the BioStabilization Systems (BoSS) Program to Transform Cell Therapy Distribution Read More »

DARPA BAA Information Innovation

DARPA I2O Office-Wide BAA Opens the Door for Breakthroughs in Information Innovation

Leave a Comment / DARPA, Emerging Technologies / By

DARPA Broad Agency Announcement HR001126S0001 The Defense Advanced Research Projects Agency (DARPA), through its Information Innovation Office (I2O), has released its FY2026 Office-Wide Broad Agency Announcement (BAA) seeking groundbreaking research that can fundamentally reshape the nation’s capabilities across information science, cybersecurity, artificial intelligence (AI), and complex software systems. This solicitation, HR001126S0001, invites performers to propose

DARPA I2O Office-Wide BAA Opens the Door for Breakthroughs in Information Innovation Read More »

BARDA next generation vaccine platforms

BARDA Seeks Next-Generation Vaccine Platforms to Accelerate National Preparedness

Leave a Comment / BARDA, Life Sciences / By

New-Vaccine-Platforms-RFI_Amd-1.pdf The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), has released a new Request for Information (RFI) focused on “New Vaccine Platforms.” This solicitation seeks to better understand the current landscape of vaccine platform technologies

BARDA Seeks Next-Generation Vaccine Platforms to Accelerate National Preparedness Read More »

ARPA-H Evident Program

ARPA-H’s EVIDENT Program to Transform Behavioral Health Intervention Research

Leave a Comment / ARPA-H, Life Sciences / By

ARPA-H-RFS-EVIDENT-TA-1-3-Exploratory_Clean ARPA-H’s EVIDENT Program Seeks Objective Clinical Endpoints for Rapid-Acting Behavioral Health Treatments (1) Mental and behavioral health disorders, including depression, anxiety, and addiction, affect about half of all Americans, with treatment costs nearing $200 billion annually.  Yet, traditional diagnostics still rely heavily on subjective endpoints that fail to capture the complexity and immediacy of

ARPA-H’s EVIDENT Program to Transform Behavioral Health Intervention Research Read More »

ARPA-H AIR

EverGlade Insights: ARPA-H Launches the Autonomous Interventions and Robotics (AIR) Program

Leave a Comment / ARPA-H, Life Sciences / By

AIR+ARPA-H-SOL-26-146+Amend+01 The Advanced Research Projects Agency for Health (ARPA-H) has released a major new Innovative Solutions Opening (ISO) titled Autonomous Interventions and Robotics (AIR), marking one of the most ambitious federal investments to date in autonomous surgical systems and micro-scale medical robotics. The program seeks to fundamentally redefine how clinicians diagnose and treat life-threatening conditions

EverGlade Insights: ARPA-H Launches the Autonomous Interventions and Robotics (AIR) Program Read More »

BARDA's ASSURE Program

BARDA’s ASSURE Program to Advance Next-Generation Immune Assays

Leave a Comment / BARDA, Life Sciences / By

RPPV-26-07-ASSURE-Amendment-2 The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR), has released a new opportunity under the Rapid Response Partnership Vehicle (RRPV): the Assay Development for Superior Understanding of Response and Efficacy (ASSURE) program. Designed to strengthen national health security, ASSURE seeks to accelerate the development

BARDA’s ASSURE Program to Advance Next-Generation Immune Assays Read More »

ARPA-H MOCS Initiative

ARPA-H Launches the Making Obstetric Care Smart (MOCS) Initiative

1 Comment / ARPA-H, Life Sciences / By

MOCS_ISO_Amend_+01_20251216 The Advanced Research Projects Agency for Health (ARPA-H) has released a major new Innovative Solutions Opening (ISO) titled Making Obstetric Care Smart (MOCS). This is a national effort to transform maternal and fetal health outcomes through advanced, data-driven technologies. As maternal morbidity and mortality rise across the United States, ARPA-H is calling on innovators

ARPA-H Launches the Making Obstetric Care Smart (MOCS) Initiative Read More »

BARDA pandemic influenza vaccine partnerships

BARDA Seeks Industry Input for Pandemic Influenza Vaccine Partnerships

Leave a Comment / BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has released a new Sources Sought Notice (SSN) and Request for Information (RFI) focused on vaccine medical countermeasures (MCMs) for pandemic influenza preparedness and response. This initiative underscores BARDA’s ongoing commitment to strengthening the nation’s biosecurity

BARDA Seeks Industry Input for Pandemic Influenza Vaccine Partnerships Read More »

BARDA RAPID RFI antibodies

BARDA’s RAPID RFI for Next-Generation Antibody Design through Production

Leave a Comment / BARDA, Life Sciences / By

BARDA RAPID RFI RAPID Overview The Biomedical Advanced Research and Development Authority (BARDA) has issued a new Request for Information (RFI) titled “Rapid Antibody Production for Immunoassay Diagnostics (RAPID)”. Through this RFI, BARDA seeks to more deeply understand causes of existing bottlenecks in the antibody generation process (design through production) and assess the R&D landscape

BARDA’s RAPID RFI for Next-Generation Antibody Design through Production Read More »

BARDA advancing pathogen agnostic diagnostics

Advancing Pathogen-Agnostic Diagnostics

Leave a Comment / BARDA, Life Sciences / By

BARDA RRPV-26-09-AgDx Request for Project Proposals The Biomedical Advanced Research and Development Authority (BARDA) has released a new Request for Project Proposals (RPP-26-09-AgDx) through the Rapid Response Partnership Vehicle (RRPV), seeking to revolutionize the nation’s diagnostic readiness for infectious disease threats. Managed by Advanced Technology International (ATI), the RRPV enables collaboration between industry, academia, and

Advancing Pathogen-Agnostic Diagnostics Read More »

Scroll to Top